Avaresq Plus
Natural health product licensed in Canada
- Licence holder
- Innovata Canada Inc.
- NPN or DIN-HM
- 80101552
- Status
- Active licence
- Licence date
- 9 June 2020
- Revision date
- 15 February 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lacticaseibacillus paracasei Source : Cellule entière | 4 Milliards d'UFC | Not calculated |
| Lacticaseibacillus paracasei Source : LPC-37 | 4 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : Cellule entière | 10 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : BI-04 | 10 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : LA-14 | 5 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | 5 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : Cellule entière | 1 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : Bi-26 | 1 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Maltodextrine, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | minimum: 1 Capsule ; maximum: 4 Capsule | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Helps to manage and/or reduce the risk of antibiotic-associated diarrhoea. Source of Probiotics.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).
- Précautions et mises en garde
If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. Stop use and consult a health care practitioner/health care provider/health care professional/ doctor/physician if symptoms of digestive upset (e.g. diarrhea) occur, worsen and/or persists beyond 3 days.
Source
Official Health Canada record, licence 80101552
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging